Inicio › Linfoma folicular › Carolina del Norte › Durham
Ensayos clínicos de Linfoma folicular en Durham, NC
15 estudios para Linfoma folicular buscan participantes en centros de Durham y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
ReclutandoFase 2/3
- Duke Cancer Center Clinic 1B/C Onc/Heme ( Site 1307), Durham
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
ReclutandoFase 3
- University of North Carolina, Chapel Hill · A 10 mi de distancia
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ReclutandoFase 3
- Duke Cancer Institute, Durham
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ReclutandoFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · A 10 mi de distancia
Pain With Dementia
ReclutandoSe aceptan voluntarios sanos
- Duke University Medical Center, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Reclutando
- North Carolina Basnight Cancer Hospital, Chapel Hill · A 10 mi de distancia
Registry of Older Patients With Cancer
ReclutandoEstudio observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · A 10 mi de distancia
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
ReclutandoFase 1
- Duke Univerisity, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
ReclutandoFase 1
- Duke University, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
ReclutandoFase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · A 10 mi de distancia
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
ReclutandoFase 1
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Chapel Hill · A 10 mi de distancia
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
ReclutandoEstudio observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · A 10 mi de distancia
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
ReclutandoFase 1
- University of North Carolina, Chapel Hill · A 10 mi de distancia
Ensayos de Linfoma folicular en otras ciudades
- New York City, NY24 estudios
- Milwaukee, WI19 estudios
- Nashville, TN18 estudios
- Houston, TX18 estudios
- Boston, MA17 estudios
- Baldwin Park, CA16 estudios
- Seattle, WA15 estudios
- Columbus, OH13 estudios
- Salt Lake City, UT13 estudios
- Chicago, IL12 estudios
- San Antonio, TX12 estudios
- Philadelphia, PA12 estudios
Otros estudios en Durham
- Cáncer de seno64 estudios
- Cáncer (todos los tipos)58 estudios
- Cáncer de pulmón de células no pequeñas39 estudios
- Mieloma múltiple37 estudios
- Leucemia mielógena aguda33 estudios
- Cáncer metastásico33 estudios
- Cáncer de próstata32 estudios
- Cáncer de pulmón32 estudios
- Cáncer del colon y del recto28 estudios
- Cáncer de ovario27 estudios
- Leucemia linfocítica crónica27 estudios
- Fallo cardíaco26 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.